Condensed Statement of Shareholders' Deficiency (Unaudited) - USD ($)	3 Months Ended	6 Months Ended
	Jul. 31, 2016	Jul. 31, 2016
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, shares outstanding, Beginning balance (in shares)		1,233,853
Shareholders' deficiency, Beginning balance		$ (421,404)
Net loss	$ (20,432)	$ (39,161)
Common stock, shares outstanding, Ending balance (in shares)	1,233,853	1,233,853
Shareholders' deficiency, Ending balance	$ (460,565)	$ (460,565)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, shares outstanding, Beginning balance (in shares)		1,233,853
Shareholders' deficiency, Beginning balance		$ 1,233
Common stock, shares outstanding, Ending balance (in shares)	1,233,853	1,233,853
Shareholders' deficiency, Ending balance	$ 1,233	$ 1,233
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shareholders' deficiency, Beginning balance		81,323
Shareholders' deficiency, Ending balance	81,323	81,323
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shareholders' deficiency, Beginning balance		(503,960)
Net loss		(39,161)
Shareholders' deficiency, Ending balance	$ (543,121)	$ (543,121)